Endocrine Abstracts

Background: Liver transplantation is now recognized by ENETS as a valid indication for liver-metastatic gastro-entero-pancreatic (GEP) neuroendocrine tumors (NETs). Since 2021, the UK initiated a pilot program for selected patients — specifically, primary amenable to complete resection, low-grade, well-differentiated GEP-NETs, with 6-months stability and <50%-liver-involvement.1-3Case-summary: A 34-year-old woman, ECOG-PS-0, non-smoke...

Introduction: Until recently, lymph node metastases (LNM) in small bowel neuroendocrine tumours (SB-NETs) were classified as absent (N0) or present (N1). However, the American Joint Committee on Cancer (AJCC) updated the classification to N0, N1 (<12 positive lymph nodes), and N2 (≥12 positive LNM and/or a large mesenteric mass (MM) ≥2 cm). This updated N-classification has not been evaluated in a real-world population of patients with SB-NETs. The aim of this ...